Spleen and Liver Stiffness Is Positively Correlated with the Risk of Esophageal Variceal Bleeding

Background/Aims: Portal hypertension (PH) is a common complication of chronic liver disease and results in esophageal and gastric variceal bleeding, which is associated with a high mortality rate. Measurement of the hepatic venous pressure gradient (HVPG) is considered the gold standard for diagnosing PH and estimating the risk of varices and bleeding. In contrast, upper gastrointestinal (GI) endoscopy (UGE) can reliably demonstrate the presence of varices and bleeding. Both measures are invasive, and HVPG is mainly restricted to tertiary centers. Therefore, the development of noninvasive methods of assessing the severity of PH and the risk of variceal bleeding is warranted. Methods: We retrospectively examined the correlation of spleen stiffness (SSM) and liver stiffness measurements (LSM) with the incidence of variceal bleeding among 143 patients who underwent combined liver and spleen elastography between 2013 and 2015. Results: For 19 of 103 patients (16.8%), upper GI variceal bleeding was diagnosed and treated endoscopically. The median SSM of all patients was 35.3 kilopascals (kPa); the median LSM, 11.7 kPa. Patients with previous bleeding episodes had significantly higher SSM (75.0 kPa) and LSM (37.3 kPa) than those without a history of bleeding (SSM, 30.6 kPa; LSM, 8.2 kPa; p < 0.0001). Seventy-five patients (66.4%) underwent UGE in addition to SSM and LSM: 25 with no esophageal varices (EVs; SSM, 29.5 kPa; LSM, 11.4 kPa), 16 with EV grade 1 (SSM, 35.9 kPa; LSM, 33.4 kPa), 21 with EV grade 2 (SSM, 67.8 kPa; LSM, 27.0 kPa) and 13 with EV grade 3 (SSM, 75.0 kPa; LSM, 26.3 kPa). No statistically significant differences were found between respective grades of EV but were found between the presence and absence of varices. At a calculated cutoff level of 42.6 kPa (with application of 95% CI), SSM had sensitivity of 89% and specificity of 64% in determining the risk of bleeding, with a negative predictive value (NPV) of 0.97 (LSM sensitivity, 84%; LSM specificity, 80%; LSM NPV, 0.96 at LSM cutoff level of 20.8 kPa). When LSM (cutoff level, 20.8 kPa) and SSM (cutoff level, 42.6 kPa) were combined, the NPV was 1 (sensitivity, 100%; specificity, 55%). Conclusion: SSM and LSM as determined by FibroScan (a noninvasive method of detecting PH) is positively correlated with upper GI variceal bleeding (optimal SSM cutoff level, 42.6 kPa; optimal LSM cutoff level, 20.8 kPa). No patients with both SSM and LSM below cutoff levels had a history of bleeding complications.

[1]  W. Jeong,et al.  Diagnosis of Clinically Significant Portal Hypertension in Patients with Cirrhosis: Splenic Arterial Resistive Index versus Liver Stiffness Measurement. , 2016, Ultrasound in medicine & biology.

[2]  C. Strassburg,et al.  Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study , 2016, Gut.

[3]  T. Rodt,et al.  Evaluation of Liver and Spleen Stiffness with Acoustic Radiation Force Impulse Quantification Elastography for Diagnosing Clinically Significant Portal Hypertension , 2015, Ultraschall in der Medizin.

[4]  R. Franchis Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension , 2015 .

[5]  V. de Lédinghen,et al.  Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  Sohee Oh,et al.  The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients , 2014, Medicine.

[7]  R. de Franchis Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[8]  G. Casazza,et al.  Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. , 2014, Journal of hepatology.

[9]  F. Bronte,et al.  Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis , 2013, Journal of viral hepatitis.

[10]  A. Albillos,et al.  Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis , 2013, Scandinavian journal of gastroenterology.

[11]  V. de Lédinghen,et al.  Determination of reliability criteria for liver stiffness evaluation by transient elastography , 2013, Hepatology.

[12]  J. Bosch,et al.  Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. , 2013, Gastroenterology.

[13]  G. Casazza,et al.  Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. , 2012, Gastroenterology.

[14]  J. Bosch,et al.  Non invasive evaluation of portal hypertension using transient elastography. , 2012, Journal of hepatology.

[15]  Diana Feier,et al.  A new and simple algorithm for the noninvasive assessment of esophageal varices in cirrhotic patients using serum fibrosis markers and transient elastography. , 2011, Journal of gastrointestinal and liver diseases : JGLD.

[16]  Radu Badea,et al.  Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients , 2011, Journal of gastroenterology and hepatology.

[17]  J. Bosch,et al.  Management of varices and variceal hemorrhage in cirrhosis. , 2010, The New England journal of medicine.

[18]  V. de Lédinghen,et al.  Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. , 2009, Journal of hepatology.

[19]  M. Ziol,et al.  Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis , 2008, Alimentary pharmacology & therapeutics.

[20]  J M Peron,et al.  Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease , 2008, Alimentary pharmacology & therapeutics.

[21]  J. Barkin,et al.  Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis , 2008 .

[22]  C. Ripoll Hepatic venous pressure gradient and outcomes in cirrhosis. , 2007, Journal of clinical gastroenterology.

[23]  Ramon Planas,et al.  Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. , 2007, Gastroenterology.

[24]  Giacomo Belli,et al.  Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.

[25]  X. Forns,et al.  Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  R. Testa,et al.  Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices: Results of a Multicenter, Prospective, Validation Study , 2006, The American Journal of Gastroenterology.

[27]  N. Ganne-Carrié,et al.  Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. , 2006, Journal of hepatology.

[28]  R. Groszmann,et al.  The hepatic venous pressure gradient: Anything worth doing should be done right , 2004, Hepatology.

[29]  E Testa,et al.  Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis , 2003, Gut.

[30]  A. Gatta,et al.  Role of spleen enlargement in cirrhosis with portal hypertension. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[31]  A. Magnano,et al.  Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? , 2001, Hepatology.

[32]  A. Gressner,et al.  Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. , 1991, Clinical chemistry.